[2014] 1.1.23 Use everyday, jargon-free language to communicate information on risk. If technical terms are used, explain them clearly. [2008] 1.1.24 Set aside adequate time during the consultation to provide information on risk assessment and to allow any questions to be answered. Further consultation may be required. [2008] 1.1.25 Document the discussion relating to the consultation on risk assessment and the person's decision. [2008] 1.1.26 Offer people information about their absolute risk of CVD and about the absolute benefits and harms of an intervention over a 10-year period. This information should be in a form that: presents individualised risk and benefit scenarios and presents the absolute risk of events numerically and uses appropriate diagrams and text. [2008] 1.1.27 To encourage the person to participate in reducing their CVD risk: find out what, if anything, the person has already been told about their CVD risk and how they feel about it explore the person's beliefs about what determines future health (this may affect their attitude to changing risk) assess their readiness to make changes to their lifestyle (diet, physical activity, smoking and alcohol consumption), to undergo investigations and to take long-term medication assess their confidence in making changes to their lifestyle, undergoing investigations and taking medication inform them of potential future management based on current evidence and best practice involve them in developing a shared management plan check with them that they have understood what has been discussed. [2008, 1.1.28 If the person's CVD risk is at a level where intervention is recommended but they decline the offer of treatment, advise them that their CVD risk should be reassessed again in the future. Record their choice in their medical notes. [2008, amended 2014] 1.2 Aspirin for primary prevention of CVD 1.2.1 Do not routinely offer aspirin for primary prevention of CVD. 